ScholarLens Back to search
2016•Journal of Clinical and Translational HepatologyOpen access

Limited Knowledge of Acetaminophen in Patients with Liver Disease

Sammy Saab, Peter Konyn, Matthew R. Viramontes, Melissa Jimenez, Jonathan Grotts, Wally Hamidzadah, Veronica P Dang, Negin Esmailzadeh, Gina Choi, Francisco Durazo, Mohamed El-Kabany, Steven‐Huy B. Han, Myron J. Tong

Open full text 22 citations

Abstract

We conclude that patients with liver disease have critically low levels of knowledge of acetaminophen, putting them at risk both of acetaminophen overdose, as well as undermedication, and inadequate management of chronic pain. We recommend an increase in education efforts regarding acetaminophen dosage and its safety in the setting of liver disease. Increasing education for those at risk of low acetaminophen knowledge is essential to minimizing acetaminophen overdose rates and optimizing pain management.

Open-access reader

About this research paper

What this paper is about

We conclude that patients with liver disease have critically low levels of knowledge of acetaminophen, putting them at risk both of acetaminophen overdose, as well as undermedication, and inadequate management of chronic pain. We recommend an increase in education efforts regarding acetaminophen dosage and its safety in the setting of liver disease. Increasing education for those at risk of low acetaminophen knowledge is essential to minimizing acetaminophen overdose rates and optimizing pain management.

Why it matters

OpenAlex reports 22 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We conclude that patients with liver disease have critically low levels of knowledge of acetaminophen, putting them at risk both of acetaminophen overdose, as well as undermedication, and inadequate management of chronic pain. We recommend an increase in education efforts regarding acetaminophen dosage and its safety in the setting of liver disease. Increasing education for those at risk of low acetaminophen knowledge is essential to minimizing acetaminophen overdose rates and optimizing pain management.

Key concepts: Medicine, Acetaminophen, Liver disease, Disease, Intensive care medicine, Internal medicine, Pharmacology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Limited Knowledge of Acetaminophen in Patients with Liver Disease — Research Paper | ScholarLens